Xorptech Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-06-2024
- Paid Up Capital ₹ 0.10 M
as on 19-06-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 3821.88%
(FY 2020)
- Profit -2478.78%
(FY 2020)
- Ebitda -1391.41%
(FY 2020)
- Net Worth -18179.59%
(FY 2020)
- Total Assets 5146.33%
(FY 2020)
About Xorptech Lifescience
The Corporate was formerly known as Xorptech Infocorp Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rushirajsinh Jadeja and Amit Banker serve as directors at the Company.
- CIN/LLPIN
U24297GJ2013PTC077038
- Company No.
077038
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Oct 2013
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Xorptech Lifescience Private Limited offer?
Xorptech Lifescience Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Dentist Tools, Equipment & Supplies, Oral Care Kit, Kids, Racing Bicycles and Rickshaws, Sports Bicycles, Cosmetics, Hair & Beauty Products, Hair Care Products, Digestive System Drugs & Medicines, Digestive Drugs.
Who are the key members and board of directors at Xorptech Lifescience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Banker  | Director | 13-May-2019 | Current |
| Rushirajsinh Jadeja | Director | 13-May-2019 | Current |
Financial Performance of Xorptech Lifescience.
Xorptech Lifescience Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 3821.88% increase. The company also saw a substantial fall in profitability, with a 2478.78% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18179.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xorptech Lifescience?
In 2020, Xorptech Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Illuminati Infocorp Private LimitedActive 10 years 3 monthsRushirajsinh Jadeja and Amit Banker are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Xorptech Lifescience?
Unlock and access historical data on people associated with Xorptech Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xorptech Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xorptech Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
